Therapeutic effects of Rheumatoid Arthritis on Aspergillosis development

Therapeutic effects of Rheumatoid Arthritis on Aspergillosis development

Aspergillosis is a common fungal infection with systemic characteristics, which is caused by various species of <em>Aspergillus</em>. The infection could develop in immunocompromised and immunocompetent patients under specific circumstances. Based on the clinical features and type of inv...

Full description

Bibliographic Details
Main Author:	Ali AL-Janabi
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2020-03-01
Series:	Reviews in Clinical Medicine
Subjects:	aspergilloma aspergillosis rheumatoid arthritis tnf inhibitors
Online Access:	http://rcm.mums.ac.ir/article_15121_2838ee381264db9cf0abaa51852a3c8a.pdf

Similar Items

Pediatric Pulmonary and Thoracic Aspergillosis
by: Preeyacha Pacharn, et al.
Published: (2020-07-01)

Role of itraconazole in the management of aspergillosis in treated patients of pulmonary tuberculosis
by: Gupta P, et al.
Published: (2005-01-01)

Prevalence of Vitamin D Deficiency in Treatment-Naïve Subjects with Chronic Pulmonary Aspergillosis
by: Inderpaul Singh Sehgal, et al.
Published: (2020-10-01)

Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis
by: A. S. Kolbin, et al.
Published: (2020-05-01)

Case report: retroperitoneal aspergilloma in a patient with rheumatoid arthritis presenting as malignant tumor
by: Risa Shinoki, et al.
Published: (2018-07-01)

Role of Voriconazole in the Management of Invasive Central Nervous System Aspergillosis: A Case Series from A Tertiary Care Centre in India
by: Nitin Gupta, et al.
Published: (2020-08-01)

Cauda equina aspergilloma in an immunocompetent individual: A case report
by: Amresh S Bhaganagare, et al.
Published: (2013-01-01)

THE METABOLIC EFFECTS OF TNF INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS
by: Alexandra Jitaru, et al.
Published: (2019-12-01)

Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis
by: Josef S. Smolen, et al.
Published: (2020-08-01)

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis
by: Emna Hannech, et al.
Published: (2021-06-01)

Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs
by: M. Vomero, et al.
Published: (2019-01-01)

Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?
by: Gemma E. Hayes, et al.
Published: (2016-06-01)

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
by: Suzuki T, et al.
Published: (2018-03-01)

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis
by: Gaelle Vial, et al.
Published: (2021-01-01)

Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid Arthritis
by: Eulalia Rodríguez-Martín, et al.
Published: (2020-08-01)

Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept
by: Al-Ani N, et al.
Published: (2021-04-01)

Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis
by: Borja Hernández-Breijo, et al.
Published: (2021-06-01)

Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naïve B Cells in Patients With Rheumatoid Arthritis
by: Borja Hernández-Breijo, et al.
Published: (2021-06-01)

The Potential Role of Genomic Medicine in the Therapeutic Management of Rheumatoid Arthritis
by: Marialbert Acosta-Herrera, et al.
Published: (2019-06-01)

Rheumatoid arthritis treatment with TNF inhibitors and alternative procedures in case of its failure – results of the Polish survey in the context of EULAR recommendations
by: Małgorzata Tłustochowicz, et al.
Published: (2015-09-01)

Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
by: Yen-Ju Lin, et al.
Published: (2020-04-01)

What Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?
by: Puja Mehta, et al.
Published: (2020-04-01)

Golimumab for Rheumatoid Arthritis
by: Eleftherios Pelechas, et al.
Published: (2019-03-01)

Endobronchial aspergilloma mimicking bronchogenic carcinoma removed through flexible fiber-optic bronchoscopy
by: P Hari Lakshmanan, et al.
Published: (2017-01-01)

Aspergilloma - Presentation and management: Our experience
by: B. Sartaj Hussain, et al.
Published: (2018-01-01)

Primary aspergilloma and subacute invasive aspergillosis in two AIDS patients Aspergiloma primário e aspergilose invasiva subaguda em dois pacientes com AIDS
by: Roberto Martinez, et al.
Published: (2009-02-01)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
by: Olivera Boskovic, et al.
Published: (2020-01-01)

ADAM17 Genetic Variants and the Response of TNF-α Inhibitor in Rheumatoid Arthritis Patients
by: Kim HJ, et al.
Published: (2020-03-01)

Relapse rates after elective discontinuation of anti-TNF therapy in rheumatoid arthritis: a meta-analysis and review of literature
by: Arduino A. Mangoni, et al.
Published: (2019-03-01)

Proinflammatory cytokines profile in patients with Rheumatoid arthritis
by: Shahlaa M. Saleh, et al.
Published: (2009-04-01)

Study on Tumor Necrosis Factor-α· Gene Polymorphism in Rheumatoid Arthritis
by: Kim Kyung-Un, et al.
Published: (2007-06-01)

Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity
by: Mones M. Abu Shady, et al.
Published: (2015-07-01)

Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?
by: Przemyslaw J. Kotyla
Published: (2018-06-01)

Effect of Anti-Rheumatic Treatment on the Periodontal Condition of Rheumatoid Arthritis Patients
by: Menke J. de Smit, et al.
Published: (2021-03-01)

Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment
by: James OIiver, et al.
Published: (2021-03-01)

Comparison of therapeutic effects of different mesenchymal stem cells on rheumatoid arthritis in mice
by: Qing Zhang, et al.
Published: (2019-06-01)

Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy
by: Yi-Ming Chen, et al.
Published: (2018-12-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01)

Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data
by: Seung Min Jung, et al.
Published: (2019-05-01)

TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
by: A. A. Alshevskaya, et al.
Published: (2012-05-01)